Gorgan (Iran) population HLA genetics and anthropology.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 16 10 2019
revised: 25 11 2019
accepted: 26 11 2019
pubmed: 11 12 2019
medline: 3 10 2020
entrez: 11 12 2019
Statut: ppublish

Résumé

Gorgan (Iran) have been studied for HLA-A, -B, -C, -DRB1 and -DQB1 genes for the first time. They are Turkmen and originated in East Asia around Altai Mts; they originally spoke a Turk language classified within the Turkish-Oguz group. Peripheral blood samples were collected from Gorgan City (Iran) and HLA typed by standard methodology. HLA allele frequencies were compared with 7984 chromosomes of other World populations and it was shown existence of admixture of Siberian and Mediterranean HLA characters in this population, probably due to longlasting contact with Persians. Three new HLA extended haplotypes were found: A*01:01-B*35:01-DRB1*03:01-DQB1*02:01, A*30:01-B*13:01-DRB1*15:01-DQB1*02:01 and A*31:01-B*35:01-DRB1*15:01-DQB1*03:01. Gorgan (Iran) were most close to Chuvashians (Noth Caspian Sea, Russia) and Siberians, like Tuvinians, Mansi and Buryats in Neighbour Joining and Vista analyses. It is established a relationship of this population with Kurgan (Gorgan, Iran) archaeological mounds culture. However, their kinship with Scythians (2nd century BC) and Sarmatians (4th century AD) is obscure although both of them spoke a Persian language.

Identifiants

pubmed: 31818457
pii: S0198-8859(19)31290-X
doi: 10.1016/j.humimm.2019.11.009
pii:
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-11

Informations de copyright

Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Auteurs

Antonio Arnaiz-Villena (A)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain. Electronic address: arnaizantonio@gmail.com.

Ignacio Juarez (I)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain.

Hamidreza Joshghan (H)

Golestan University of Medical Sciences, Golestan, Iran.

Adrian Lopez-Nares (A)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain.

Diego Rey (D)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain.

Alvaro Callado (A)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain.

Alejandro H-Sevilla (A)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain.

Farzad Rashidi (F)

Department of Immunology, University Complutense, School of Medicine, Madrid, Spain.

Behrouz Nikbin (B)

Molecular Immunology Research Center, Medical School, Tehran University of Medical Sciences, Tehran, Iran.

Ali Amirzargar (A)

Molecular Immunology Research Center, Medical School, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH